Press release
Emerging Trends to Reshape the Osteoporosis Drugs Market: Innovative Solutions In Osteoporosis Treatment With Teriparatide Injectable For Affordable And Convenient Patient Care as a Key Influencer
Osteoporosis Drugs
Osteoporosis Drugs Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for osteoporosis medication has been consistently expanding in recent years. It's projected to increase from $12.48 billion in 2024 to $12.85 billion in 2025, with a compound annual growth rate (CAGR) of 3.0%. Factors such as an aging population, heightened awareness and diagnosis, lifestyle aspects, government interventions, and healthcare regulations have contributed to the growth during the historical period.
Osteoporosis Drugs Market Size Forecast: What's the Projected Valuation by 2029?
Over the next several years, the market for osteoporosis drugs is predicted to experience consistent growth. By 2029 it is anticipated to expand to $14.2 billion, with a compound annual growth rate (CAGR) of 2.5%. This growth during the predicted period can be credited to factors such as the ongoing trend towards an aging population, advancement in treatment alternatives, heightened attention on men's bone health, patient enlightenment and activation, universal health policies, and insurance inclusions. Noteworthy trends for the forecast period include personalized treatment methods, research into combined therapies, a focus on strategies to prevent fractures, investment in research and development for groundbreaking drug targets, and cooperative efforts towards drug development.
View the full report here:
https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report
What Are the Drivers Transforming the Osteoporosis Drugs Market?
An increase in osteoporosis cases is predicted to boost the osteoporosis drug market's expansion. Osteoporosis, a bone disorder resulting from declining bone mineral density and bone mass, or alterations in bone quality or structure, is more prevalent in individuals who consume less calcium. Osteoporosis medications, which enhance bone mineral density and avert fractures, are thus becoming more relevant. For example, the Australian Institute of Health and Welfare Australia-Government agency's data from June 2024 indicates that osteoporosis was responsible for 2,659 deaths, or 10.2 deaths per 100,000 population, in 2022. This accounted for 1.4% of all deaths. Hence, the escalating incidence of osteoporosis is fueling the osteoporosis drugs market's growth.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9102&type=smp
What Trends Will Shape the Osteoporosis Drugs Market Through 2029 and Beyond?
Leading businesses in the osteoporosis drugs market are progressing with the application of innovative solutions in the sector. For example, Apotex Inc., a pharmaceutical corporation based in Canada, introduced an injectable drug for Osteoporosis Treatment named Teriparatide, in November 2023. The prefilled teriparatide injection pen, which contains 250 mcg/mL, can provide 28 daily doses of 20 mcg each per pen. It is designed for single-patient use, offering patients an affordable and essential treatment option.
Which Segments in the Osteoporosis Drugs Market Offer the Most Profit Potential?
The osteoporosis drugs market covered in this report is segmented -
1) By Type: Bisphosphonates, Selective Estrogen Receptor Modulators (SERMs), RANK Ligand Inhibitors
2) By Administration: Oral, Injectable
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Sales
4) By Application: Primary Osteoporosis, Secondary Osteoporosis
Subsegments:
1) By Bisphosphonates: Alendronate, Risedronate, Ibandronate, Zoledronic Acid
2) By Selective Estrogen Receptor Modulators (SERMs): Raloxifene, Bazedoxifene
3) By RANK Ligand Inhibitors: Denosumab
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9102&type=smp
Which Firms Dominate the Osteoporosis Drugs Market by Market Share and Revenue in 2025?
Major companies operating in the osteoporosis drugs market include Pfizer Inc., F. Hoffmann La Roche Ltd., Merck & Co Inc., Novartis AG, Bristol Myers Squibb Company, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Asahi Kasei Pharma Corporation, Viatris Inc., Teva Pharmaceutical Industries Ltd, Mylan N.V., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Ipsen, Kyowa Kirin Co Ltd., Dr. Reddy's Laboratories Ltd., Cipla Limited, Recordati S.p.A., Cadila Healthcare Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Sunovion Pharmaceuticals Inc., Theramex, Radius Health Inc., Strides Pharma Science Limited, Apotex Inc.
Which Regions Offer the Highest Growth Potential in the Osteoporosis Drugs Market?
North America was the largest region in the osteoporosis market in 2024. The regions covered in the osteoporosis drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9102
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Emerging Trends to Reshape the Osteoporosis Drugs Market: Innovative Solutions In Osteoporosis Treatment With Teriparatide Injectable For Affordable And Convenient Patient Care as a Key Influencer here
News-ID: 4183268 • Views: …
More Releases from The Business Research Company
Emerging Trends to Drive Personalized Medicine Market Growth at 11.4% CAGR Throu …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Personalized Medicine Market Size Growth Forecast: What to Expect by 2025?
There has been significant growth in the personalized medicine market size in the past few years. The market is projected to expand from a size of $386.27 billion in 2024 to $422.9 billion in 2025, representing a compound…
2025 Skin Care Supplements Industry Trends Report: Long-Term Outlook Through 203 …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Skin Care Supplements Market Size By 2025?
In recent times, the skin care supplements market has seen a robust expansion. It is projected to elevate from $2.85 billion in 2024 to $3.06 billion in 2025, marking a compound annual growth rate (CAGR) of 7.2%. The…
Major Growth Driver Identified in 2025 Peanut Allergy Treatment Market: Driving …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Postpartum Health Supplements Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been a robust expansion of the postpartum health supplements market. Its value is expected to surge from $1.38 billion in 2024 to $1.5 billion in 2025, with an average annual growth rate…
Major Growth Driver Identified in 2025 Peanut Allergy Treatment Market: Driving …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Peanut Allergy Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the peanut allergy treatment market has seen a hefty expansion. The market size is set to swell from $0.45 billion in 2024 to $0.5 billion in 2025, with a compound annual…
More Releases for Osteoporosis
Rising Prevalence Of Osteoporosis Fuels Growth In The Osteoporosis Drug Market: …
The Osteoporosis Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Osteoporosis Drugs Market Size During the Forecast Period?
The market for medications for osteoporosis has seen a consistent rise in recent years. The current market value of $12.33 billion in 2024…
Rising Prevalence Of Osteoporosis Spurs Momentum In Postmenopausal Osteoporosis …
The Postmenopausal Osteoporosis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Postmenopausal Osteoporosis Treatment Market Size and Its Estimated Growth Rate?
The market for treatment of postmenopausal osteoporosis has seen a steady increase in size over the recent years. It's projected…
Osteoporosis Drug Market, By Type (Primary Osteoporosis and Secondary Osteoporos …
Osteoporosis is a condition of bone weakening or bones becomes fragile and likely to break. In other words, osteoporosis is a condition wherein the bone density decreases. This is specially witnessed in old age people. Osteoporosis brings along back pain, stooped posture, bone fracture and tooth loss.
View Detailed Report" https://www.databridgemarketresearch.com/reports/global-osteoporosis-drug-market
The global osteoporosis drug market is experiencing steady growth driven by factors such as the increasing aging population, rising prevalence of…
Osteoporosis Drugs: The Complete Review
Medication for osteoporosis increases bone mineral density and reduces fracture risk. Some osteoporosis medications promote bone growth while others reduce bone loss.
The bones may begin to deteriorate as age more quickly than the body can heal them. The doctor could determine that people have osteoporosis if they have significant bone density loss.
To receive free sample pages of this report@ https://www.psmarketresearch.com/market-analysis/osteoporosis-drugs-market/report-sample
Although osteoporosis cannot be treated, it can be slowed down or…
Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.…
Global Postmenopausal Osteoporosis Therapeutics Market
The Postmenopausal Osteoporosis Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related…
